Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Sarepta Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

93 comunicati stampa

Guarda tutti i comunicati
22/10/2026
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
14/10/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Eventi
Industria
Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/09/2026
Mercato azionario
Biotecnologia
Salute
Scienza
Farmaceutica
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
30/09/2026
Eventi
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sarepta Therapeutics Presents New Data at 2026 World Muscle Society Annual Congress Demonstrating Safety and Clinically Meaningful Functional Benefit of ELEVIDYS (delandistrogene moxeparvovec) in Older Ambulatory Patients with Duchenne
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
25/09/2026
Eventi
Industria
Scienza
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
24/09/2026
Eventi
Scienza
Biotecnologia
Medicina - Varie
Cardiologia
Salute
Farmaceutica
Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27th Annual Neuromuscular Study Group Scientific Meeting
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
08/09/2026
Industria
Biotecnologia
Igiene alimentare
Politica Locale
Salute
Vetrine/Shopping
Farmaceutica
Scuola/Istruzione
Associazioni/Professionisti
Università
Scienza
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program, for the 2026-2027 Academic Year
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
31/08/2026
Eventi
Web e Social Network
Salute
Biotecnologia
Scienza
Farmaceutica
Cardiologia
Sarepta Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
05/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
29/07/2026
Igiene alimentare
Salute
Scienza
Farmaceutica
Biotecnologia
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fonte
Sarepta Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0